Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Clinical Trials Unit has opened within the Department of Psychiatry - the Oxford Brain Health Clinical Trials Unit - it is the only mental health-dedicated Clinical Trials Unit in the UK. It opened in September 2019 and has replaced the former Oxford Cognitive Health and Neuroscience Clinical Trials Unit.

The Oxford Brain Health Clinical Trials Unit (OBHCTU) aims to collaborate with academics and clinicians across the Department of Psychiatry and Oxford Health NHS Foundation Trust in order to support high quality research. The unit is particularly keen to support translational research using innovative methods and offers advice and support in all aspects of the planning, conducting and reporting of clinical trials.

OBHCTU projects currently include both non-commercial efficacy trials designed to reduce the uncertainties associated with current treatments and early phase trials evaluating potential new treatments. The Clinical Trial Unit (CTU) is also working to increase research productivity and recruitment into trials.

We can provide advice in terms of developing research applications and trial design. We therefore would encourage all researchers to contact us early on in their design process to see if we can offer any personalised support. - Dr Vanessa Raymont, Director of Oxford Brain Health Clinical Trials Unit. 

The following services can be provided

  • Research study design and methodological advice
  • Trial management support and advice (including single centre, multicentre and global studies)
  • Quality assurance support and advice (including single centre, multicentre and global studies)
  • Statistical support and advice
  • Training and development for researchers, as well as, their teams (including bespoke courses)
  • Independent research/researcher support
  • Central reviewer services and vendor selection

 

There are a number of working groups and an oversight group, which help steer the CTU comprising of senior academics from the Department of Psychiatry.

Clinical trials are not the only type of studies support is provided for, contact Dr Vanessa Raymont vanessa.raymont@psych.ox.ac.uk for more information. The trial adoption process will be made available to all very soon.

Similar stories

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.

Life and Mind Building construction tops out

Another milestone was reached this week with the topping out ceremony of the new Life and Mind Building.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

Director of MRC Brain Network Dynamics Unit appointed

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.